title: [Changes of the serum adiponectin during treatment with peginterferon α-2a and ribavirin for chronic hepatitis C].
authors.affiliation: Department of Liver Disease, the Second Hospital of Nanjing, Nanjing, China. huangping606@sohu.com
authors.forename: Ping
authors.initials: P
authors.lastname: Huang
authors.forename: Yong-feng
authors.initials: YF
authors.lastname: Yang
authors.forename: Qing-fang
authors.initials: QF
authors.lastname: Xiong
authors.forename: Yan-dan
authors.initials: YD
authors.lastname: Zhong
mesh_terms: D052242:Adiponectin / Q000097:blood*; D000293:Adolescent; D000328:Adult; D005260:Female; D019698:Hepatitis C, Chronic / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000494:pharmacology; D012254:Ribavirin / Q000494:pharmacology*; D055815:Young Adult
chemical_list: D052242:Adiponectin; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a